Ashita J Tolwani (Ashita Tolwani)

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 4

Top Topics

Replacement Therapy

Randomized Controlled Trial

Tyrosine Kinase

Top Venues

Clinical journal of the American Society of Nephrology : CJASN

Journal of clinical pharmacology

University of Alabama at Birmingham

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Alabama at Birmingham

United States

Professor of Medicine :: Nephrology

Publications

Joao Pedro Teixeira, Ashita J Tolwani
Practice Variation in the Prescription of Volume Removal with Acute KRT: A Call for Randomized Controlled Trials. Clinical journal of the American Society of Nephrology : CJASN (2023)
Javier A Neyra, Ashita J Tolwani
Nephrologists Rather Than Intensivists Should Manage Kidney Replacement Therapy in the ICU: COMMENTARY. Kidney360 4 (1) (2023)
Javier A Neyra, Ashita J Tolwani
Nephrologists Rather Than Intensivists Should Manage Kidney Replacement Therapy in the ICU: COMMENTARY. Kidney360 4 (1) (2023)
Soo-Min Jang, Katherine N Gharibian, Susan J Lewis, William H Fissell, Ashita J Tolwani, Bruce A Mueller
A Monte Carlo Simulation Approach for Beta-Lactam Dosing in Critically Ill Patients Receiving Prolonged Intermittent Renal Replacement Therapy. Journal of clinical pharmacology 58 (10) (2018)